Chinese AI startup DeepSeek is in preliminary talks with investors for fresh capital at a ~$71B valuation, just months after closing a $7B funding round at ~$52B. The rapid fundraising reflects the company's accelerated growth trajectory.
DeepSeek is exploring new funding options at approximately $71 billion, according to sources familiar with the matter. The valuation represents a significant jump from the startup's previous round in May, when it raised roughly $7 billion at a $52 billion valuation.
The unusually swift pace of capital raises underscores DeepSeek's aggressive expansion strategy. The Chinese AI firm is prioritizing infrastructure development as it scales its operations in a competitive landscape dominated by both domestic and international players.
DeepSeek has emerged as a notable contender in the AI sector, particularly with its focus on efficient model development. The startup's ability to attract substantial capital at accelerating valuations signals investor confidence in its technology and market positioning.
The preliminary nature of current talks means funding terms and final valuation remain subject to negotiation. However, the significant step-up from May's $52 billion valuation demonstrates momentum in the company's fundraising efforts.
This capital injection would support DeepSeek's infrastructure expansion, a critical component for AI startups developing large language models and deploying computational resources. Such infrastructure investments typically include data centers, GPU clusters, and associated technical capabilities.
DeepSeek's fundraising activity reflects broader trends in the AI sector, where well-positioned startups continue to attract investor capital despite market volatility. The company's valuation growth over a matter of months illustrates the capital intensity of AI development and investor appetite for promising AI ventures.
The fundraising comes as Chinese AI companies navigate regulatory environments while competing globally. DeepSeek's progress in securing multiple rounds of funding at rising valuations indicates its ability to execute on its technical roadmap and maintain investor support.
Miles Wang, an OpenAI researcher focused on AI-accelerated scientific discovery, is departing the company to start a new AI drug discovery venture. The startup is in talks to raise $200 million at a $2 billion valuation.
Hadrius, an NYC-based fintech startup, secured $22 million in Series A funding led by CRV with backing from Y Combinator. The company provides AI-native compliance software for financial services firms.
InstaLILY, an enterprise automation startup, has raised $60 million in Series B funding led by Energize Capital, bringing its total funding to nearly $100 million.
Adapter, an infrastructure platform enabling AI agents and applications to leverage and control data, has emerged from stealth with $17.8 million in funding led by GV.